Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Longevity Vision Holding, based in New York, New York, is a venture capital firm founded to advance breakthroughs in longevity. Established by a team of experts, the organization focuses on developing and investing in innovative solutions that address age-related diseases. The firm has a fund size of $100 million and currently manages a diverse portfolio of 18 companies.
Founded in 2018 or 2019, Longevity Vision has evolved to become a significant player in the longevity investment space. The firm emphasizes a differentiated investment strategy that targets validated scientific concepts with clear pathways to market. Their office is located at 57 West 57th Street, 4th Floor, New York, New York 10019 USA. The firm has gained recognition for its commitment to transforming healthcare through investments in cutting-edge technologies and therapies.
Longevity Vision's notable milestones include the establishment of the BOLD Longevity Growth Fund in 2023, co-founded by Sergey Young, which reviews approximately 200 longevity companies annually. This initiative further solidifies the firm's position in the longevity investment landscape.
Longevity Vision invests across multiple stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C. The firm targets a diverse range of sectors related to longevity and healthcare, including biotech, healthcare, artificial intelligence, gene therapy, cancer detection, and organ regeneration technologies. Their investment strategy emphasizes advancing therapies that address the pathways of aging, aiming to cover a broad spectrum of diseases through their portfolio.
The organization seeks innovative solutions that can significantly impact aging and age-related diseases. They prioritize investments in validated scientific concepts and viable business models, focusing on technologies that have clear FDA approval pathways leading toward potential IPO exits. Longevity Vision's approach includes a commitment to making longevity breakthroughs accessible and affordable, aligning with their mission to transform healthcare.
Longevity Vision's portfolio consists of 18 companies, showcasing a diverse range of innovative solutions in the longevity and healthcare sectors. Notable portfolio companies include:
David Kirn - Founder, experienced in biotechnology and longevity investments.
David Schaffer - Founder, known for his work in healthcare innovation.
Theresa Janke - Founder, brings expertise in biotech and investment strategies.
Melissa Kotterman - Founder, focuses on operational support for portfolio companies.
David Berry - Founder, has a background in healthcare and technology.
Gabriel Otte - Founder, specializes in longevity research and investment.
Riley Ennis - Founder, known for his work in biotechnology.
Charles Roberts - Founder, experienced in healthcare investments.
Robert Langer - Founder, a prominent figure in biotechnology and drug delivery systems.
Daniel Anderson - Founder, focuses on innovative healthcare solutions.
Alex Zhavoronkov - Founder, known for his expertise in AI and longevity.
Geoffrey von Maltzahn - Founder, experienced in biotech investments.
Jacob Rubens - Founder, focuses on healthcare innovation.
Noubar Afeyan - Founder, a well-known figure in the biotech industry.
Avak Kahvejian - Founder, specializes in longevity and healthcare investments.
Connor Landgraf - Founder, known for his work in biotechnology.
Jason Bellet - Founder, focuses on operational support for startups.
Tyler Crouch - Founder, experienced in healthcare investments.
Sandeep Akkaraju - Founder, known for his expertise in biotech.
Janusz Bryzek - Founder, focuses on innovative healthcare solutions.
Yusuf Haque - Founder, experienced in longevity investments.
John Kokulis - Founder, known for his work in biotechnology.
Michael Hufford - Founder, focuses on healthcare innovation.
Eric Lagasse - Founder, experienced in biotech and healthcare.
David Sinclair - Founder, a prominent figure in longevity research.
Tristan Edwards - Founder, known for his expertise in healthcare.
James Mellon - Founder, focuses on longevity investments.
Gregory Bailey - Founder, experienced in biotech investments.
Declan Doogan - Founder, known for his work in healthcare.
James Peyer - Founder, focuses on innovative solutions in longevity.
Christian Angermayer - Founder, a well-known figure in the biotech industry.
Robert Hariri - Founder, experienced in healthcare and biotech.
Peter Diamandis - Founder, known for his work in innovation and longevity.
Tony Robbins - Founder, focuses on personal development and longevity.
To pitch to Longevity Vision, startups should send an email to info@longevity.vision. The pitch deck should include a comprehensive overview of the business model, technology, market opportunity, and team background. It is advisable to highlight any scientific validation and potential impact on age-related diseases.
While specific response time expectations are not disclosed, founders should anticipate a thorough review process given the firm's focus on validated scientific concepts. Warm introductions are beneficial but not mandatory.
As of March 2026, Longevity Vision has actively deployed capital across 18 portfolio companies, focusing on therapeutic platforms targeting the root causes of aging and AI-enabled health tech. The firm has made notable investments in platforms for gene therapy, cancer detection, and AI-driven healthcare solutions.
In 2023, Sergey Young co-founded the BOLD Longevity Growth Fund, which reviews approximately 200 longevity companies annually with the goal of investing in around 5 per year. This initiative highlights Longevity Vision's commitment to supporting breakthroughs in longevity and healthcare.
What are Longevity Vision's investment criteria?
Longevity Vision invests in innovative solutions targeting age-related diseases, focusing on validated scientific concepts and viable business models. They cover multiple stages of development, from pre-seed to Series C.
How can startups apply or pitch to Longevity Vision?
Startups can reach out via email at info@longevity.vision to pitch their ideas. It is advisable to include a detailed overview of the business model, technology, and potential impact on longevity.
What makes Longevity Vision different from other investors?
The firm emphasizes a differentiated and de-risked investment strategy, focusing on validated scientific concepts with clear pathways to market. Their extensive network of experts in longevity and healthcare adds significant value to portfolio companies.
What is the geographic scope of Longevity Vision's investments?
Longevity Vision primarily focuses on North America for its investments, targeting companies that are developing innovative solutions in the longevity and healthcare sectors.
What is the typical check size for investments?
While specific check sizes are not disclosed, Longevity Vision invests across various stages, indicating a flexible approach to funding based on the needs of the portfolio companies.
What kind of post-investment involvement does Longevity Vision have?
Longevity Vision provides strategic guidance and access to resources necessary for growth and development, leveraging its extensive network of experts in the longevity and healthcare sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.